Peripheral neuropathy decisions — 2025

The Board remands the claims for service connection for various conditions, including a psychiatric condition, diabetes, peripheral neuropathy, and knee and headache issues, to allow for additional development of the record.

The Board remands the claims for service connection for cataracts and diabetic neuropathy of the bilateral lower extremities as further development is necessary to provide adequate medical opinions.

The Board remands the issue of entitlement to a disability rating in excess of 10 percent for left upper extremity peripheral neuropathy due to an inadequate VA examination.

The Board remands the claims for additional medical opinions addressing whether the Veteran's claimed disabilities are etiologically related to his in-service TERA of exposure to commercial herbicides.

The Board granted service connection for right and left upper extremity peripheral neuropathy, and denied higher ratings for peripheral artery disease and atherosclerotic vascular disease of the lower extremities.

The Board remands the claims for higher ratings and earlier effective dates for kidney disability, diabetes mellitus, type II, hypertension, lower extremity peripheral neuropathy, anxiety disorder, and PTSD due to pre-decisional duty to assist errors.

The Board remands the claim for a rating in excess of 10 percent for right knee patellofemoral pain syndrome with knee neuropathy due to deficiencies in the VA examination and lack of relevant private treatment records.

The Board denied service connection for left shoulder condition, bilateral peripheral neuropathy, diabetes mellitus type II, prostate cancer, and hypertension as the evidence did not support a finding that any of these conditions were related to the Veteran's active duty service.

The Board granted an earlier effective date of August 11, 2017, for service connection for diabetes mellitus type II with erectile dysfunction and associated peripheral neuropathy in both lower extremities.

The Board remands the matters of entitlement to an initial rating in excess of 10 percent for right and left leg peripheral neuropathy due to a pre-decisional duty to assist error.

The Board denied increased ratings for diabetic peripheral neuropathy, diabetes mellitus, and knee limitations but granted separate 10 percent ratings for left and right knee flexion due to pain.

The Board remands the claims for service connection for diabetes and related conditions due to a duty to assist error.

The Board denied service connection for various conditions, including glaucoma, diabetes, and neuropathy, as the probative evidence did not support a finding that these conditions were incurred in or caused by active military service.

The Board denied service connection for peripheral neuropathy of the right and left upper extremities, ankle instability, bilateral pes planus/flat feet, left foot hammertoes, right foot hammertoes, left foot hallux valgus, right foot hallux valgus, right hip pain, and left hip pain as there was no evidence that these conditions were related to the Veteran's active-duty service.

The appeal for service connection and increased ratings for various conditions, including right and left hip conditions and diabetic peripheral neuropathy of the lower extremities, was dismissed.

The Board remands the claims for an earlier effective date, special monthly compensation, and TDIU due to incomplete medical evidence regarding the severity of peripheral neuropathy without considering medication effects.

The Board denied service connection for various conditions, including high cholesterol or unspecified hyperlipidemia, tuberculosis (TB), traumatic brain injury, migraines, low back disability, neck disability, and others. The claims were not supported by sufficient evidence of a current disability related to the Veteran's military service.

The Board granted an initial rating of 40 percent for fibromyalgia but denied service connection for bilateral neuropathy of the upper extremities.

The Board granted service connection for left and right lower extremity peripheral neuropathy, effective August 14, 2023.

The Board granted service connection for prostate cancer residuals, Parkinson's disease, ischemic heart disease, hypothyroidism, peripheral neuropathy, and testicular disability on a basis other than the PACT Act.